Get startedLog in
    Picture of Kazia Therapeutics logo

    KZA — Kazia Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    All News

    Brief: Kazia Says Phase II Study Of Paxalisib In Brain Metastases Advances To Expansion Stage In Breast Cancer Brain Metastases Cohort

    Picture of Kazia Therapeutics logoKazia Therapeutics
    07/06/2022 12:12
    June 7 (Reuters) - Kazia Therapeutics Ltd  KZA.AX :
    * PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES
TO
EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT

Source text for Eikon:  ID:nPn85JLhQa 
Further company coverage:  KZA.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kazia Therapeutics

    See all news